Your Directors are pleased to present Your Company's 41st (Forty First) Annual Report on the business and operations, together with the Audited Financial Statements (Consolidated and Standalone) for the Financial Year ended March 31, 2026.
|
Particulars
|
Consolidated
|
Standalone
|
|
Financial year ended March 31, 2026
|
Financial year ended March 31, 2025 (Restated)
|
Financial year ended March 31, 2026
|
Financial year ended March 31, 2025 (Restated)
|
|
Total Revenue
|
4264.69
|
3655.77
|
3298.39
|
2829.29
|
|
Profit for the year before finance charges, depreciation, share of net loss of associates, exceptional item and tax
|
377.02
|
315.33
|
266.71
|
238.65
|
|
Less: Finance charges
|
82.30
|
80.06
|
49.39
|
46.86
|
|
Profit for the year before depreciation, share of net loss of associates, exceptional item and tax
|
294.72
|
235.27
|
217.32
|
191.79
|
|
Less: Depreciation
|
90.08
|
80.22
|
52.30
|
45.90
|
|
Profit for the year before share of net loss of associates exceptional item and tax
|
204.64
|
155.05
|
165.02
|
145.89
|
|
Less: Share of net loss of associates
|
0.43
|
-
|
-
|
-
|
|
Profit for the year before exceptional item and tax
|
204.21
|
155.05
|
165.02
|
145.89
|
|
Less: Exceptional Item
|
4.57
|
-
|
4.37
|
-
|
|
Profit for the year before tax
|
199.64
|
155.05
|
160.65
|
145.89
|
|
Less: Provision for Tax
|
|
|
|
|
Current Tax
|
43.00
|
39.00
|
38.24
|
35.18
|
|
Deferred Tax
|
7.61
|
0.79
|
3.04
|
1.75
|
|
Profit for the year after Tax
|
149.03
|
115.26
|
119.37
|
108.96
|
|
Other Comprehensive Income
|
2.02
|
0.46
|
0.73
|
0.66
|
|
Total Comprehensive Income
|
151.05
|
115.72
|
120.10
|
109.62
|
YEAR IN RETROSPECT
Your Company has once again delivered record operational performance, aligned with the Board's expectations and guidance, delivering its highest-ever annual Profit After Tax ('PAT') of Rs.149.03 Crores and reinforcing its leadership position in the industry.
Despite a challenging global environment marked by geopolitical headwinds, elevated input and petrochemical prices, and continued softness in FMCG consumption, your Company achieved its highest-ever annual revenue and profits, while continuing to strengthen existing business relationships and its customer base. In addition, it further expanded its operations by commercialising new manufacturing facilities, integrating recent acquisitions and diversifying its product portfolio into newer, higher-margin areas, laying the foundation for sustained growth.
During the Financial Year 2025-26, consolidated revenue from operations increased by approximately 17% over the previous year, reaching Rs. 4,251.04 Crores, as compared to Rs. 3,638.71 Crores (Restated) in the previous year, while total income rose to Rs. 4,264.69 Crores from Rs. 3,655.77 Crores for the previous year. Consolidated EBITDA grew
by 20% to Rs. 377.00 Crores from Rs. 315.30 Crores for the previous year, and Consolidated PAT grew by 29%, rising to Rs.149.03 Crores from Rs. 115.26 Crores in the previous year.
This performance demonstrates your Company's resilience and its ability to deliver consistent, compounding growth, despite challenging global conditions and continued slowdown in FMCG consumption, with revenue, EBITDA, PBT and PAT recording a compound annual growth rate of 20%, 34%, 30% and 35% respectively over the last four years (FY22 to FY26).
Your Directors are pleased to inform you that HFL Multiproducts Private Limited ('HMPL'), Wholly-Owned Subsidiary of your Company, continued to scale up its plant operations during the year under review, having successfully integrated the business undertaking acquired from MMG Enterprises Private Limited at IDCO Plot No B/6, Food Processing Park, Makundaprasad, District Khurda, Odisha, which is engaged in the manufacturing, processing, and packaging of bottled water and associated components. During the year under review, HMPL reported a turnover of Rs. 21.52 Crores, as compared to Rs.13.53 Crores in the previous Financial Year, and a Net Loss of Rs. 3.89 Crores for the year, as compared to Net Loss of Rs. 3.13 Crores in the previous Financial Year.
Your Directors remain confident that HMPL will contribute meaningfully to the consolidated revenues of your Company in the coming years and continue its growth trajectory.
Your Directors are pleased to report that HFL Consumer Products Private Limited ('HCPPL'), a Wholly-Owned Subsidiary of your Company, achieved a strong operational performance for the year ended March 31, 2026. During the year, HCPPL further strengthened its footprint in the Ice Cream contract manufacturing business, including through the acquisition of one ice cream cone and one sleev manufacturing facilities at Sinnar, Nashik, for a consideration of Rs. 26.25 Crores. HCPPL reported total revenue from operations of Rs. 326.47 Crores, as compared to Rs. 229.90 Crores in the previous year, and recorded highest -ever PAT of Rs. 23.03 Crores for the year under review, as compared to PAT of Rs. 3.95 Crores in the previous year. Your Directors remain optimistic that HCPPL will continue to contribute meaningfully to the Company's
consolidated profitability in the upcoming financial year, driven by ongoing expansion and market demand.
Your Directors are further pleased to share that the Company's strategic acquisition of Aero Care Personal Products LLP ('ACPPL') continued to strengthen the Company's presence in the Color Cosmetics segment during the year under review an important part of our consumer product portfolio. ACPPL reported a highest- ever turnover of Rs. 135.51 Crores for Financial Year 2025-26, as compared to turnover of Rs.131.02 Crores in the previous Financial Year, and a PAT of Rs. 6.19 Crores, as compared to PAT of Rs. 5.16 Crores in the previous year. With this trajectory, your Directors anticipate continued contributions from ACPPL to the Company's consolidated income in the coming financial year, reinforcing our growth momentum and diversification strategy.
During the year under review, HFL Healthcare and Wellness Private Limited ('HHWPL'), a wholly-owned subsidiary of your Company is significantly engaged in the OTC Healthcare and Wellness sector, continued its growth momentum. HHWPL reported a turnover of Rs. 129.48 Crores, up from Rs. 92.99 Crores in the previous year, and a PAT of Rs. 3.79 Crores, compared to PAT of Rs. 9.38 Crores in the prior period. Your Directors remain confident that this subsidiary will contribute significantly to the Company's consolidated performance and support its expansion into global OTC Healthcare and Wellness markets.
Your Directors are pleased to report that the Company's acquisition of KNS Shoetech Private Limited ('KNS'), now a Material Wholly-Owned Subsidiary of your Company, engaged in the manufacturing and supply of sports shoes and sneakers, continued to scale the Company's footprint in the footwear segment. KNS reported its highest-ever turnover of Rs. 411.07 Crores in Financial Year 2025-26, as compared to turnover of Rs. 390.91 Crores in the previous Financial Year. KNS reported a Net Profit of Rs. 1.52 Crores for the Financial year, as compared to a Net Loss of Rs. 8.17 Crores in the previous Financial Year.
Your Directors remain confident that this acquisition will contribute meaningfully to the Company's consolidated growth and position it as a key player in the global contract manufacturing space for sports shoes and sneakers, with the management continuing to prioritise diversification of the segment's customer base as a near-term lever to mitigate raw-material price volatility.
Your Board is confident that customers will continue to look at your Company's track record of executing greenfield and brownfield projects flawlessly and integrating acquisitions seamlessly, and continue to propel us towards sustained industry leadership in contract manufacturing, enhanced customer trust, and long-term value creation.
During the year under review, your Company's greenfield ice cream project at 'Nashik', which commenced commercial production in May 2025, was ramped up further, enabling your Company to better leverage the factory and enhance capacity to serve key customers. Building on this, your Company also commissioned Phase 1 of a new greenfield ice cream facility at 'Panipat' in April 2026, further expanding its footprint in the ice cream contract manufacturing business to serve customers in North India.
During the year under review, the Scheme of Arrangement involving the demerger of the Contract Manufacturing Business (Nashik) of Avalon Cosmetics Private Limited into the Company and the amalgamation of Vanity Case India Private Limited with the Company, sanctioned by the Hon'ble National Company Law Tribunal, Mumbai Bench, on February 25, 2026, became effective from closing of business hours on March 31, 2026, further consolidating the Group's FMCG contract manufacturing operations.
REVISION IN FINANCIAL STATEMENT(i) Merger Information - Nashik Manufacturing Unit of Avalon Cosmetics Private Limited
The Scheme of Arrangement ('the Scheme'), presented under Section 230 to 232 and other applicable provisions of the Companies Act, 2013 read with the rules prescribed thereunder, for the business combination of Nashik Manufacturing Unit of Avalon Cosmetics Private Limited ('ACPL') with your Company was approved by the Hon'ble National Company Law Tribunal (Mumbai Bench) vide its order dated February 25, 2026 ('the NCLT Order'). The Certified copy of the NCLT Order was filed with Registrar of Companies on March 31, 2026. Consequently, the Scheme become operative from closing of business hours on March 31, 2026 and effective from April 01, 2024 i.e. appointed date.
The said business combination has been accounted under the 'pooling of interests' method in accordance with Appendix C of Ind AS 103 'Business Combination' and the previously issued financial statements of the Company for the year ended March 31, 2025 included in this statement have been restated to give effect to the Scheme. All the assets and liabilities of Nashik Manufacturing unit of ACPL have been transferred to and vested in the Company at it's carrying value w.e.f. April 01, 2024 and amount Rs. 0.34 Crores is recorded as debit to the capital reserve on account of the Scheme. In consideration of business combination, the Company will allot 16,80,939 equity shares Rs. 2 each credited as fully paid-up shares of the Company to the shareholders of ACPL for each equity share held in ACPL. The same is presented as "Share Pending Issuance" under "Other Equity" as at April 01, 2024.
Pursuant to the business combination between Nashik Manufacturing Unit of ACPL and the Company with effect from April 01, 2024, the profit attributable to the equity shareholders for the comparative year has been restated to include the figures of Nashik Manufacturing unit of ACPL. Accordingly, as per the requirement of the IND AS 33 'Earnings Share', the Basic and Diluted earnings per share of the comparative year has been restated taking into consideration the equity shares issued to the shareholders of ACPL. Further, the current tax and deferred tax amounts in the comparative year has been restated owing to the said business combination.
(ii) Amalgamation Information - Vanity Case India Private Limited ('VCIPL')
The Scheme of Arrangement ('the Scheme'), presented under Section 230 to 232 and other applicable provisions of the Companies Act, 2013 read with the rules prescribed thereunder, for the amalgamation of Vanity Case India Private Limited ('VCIPL') with the Company was approved by the Hon'ble National Company Law Tribunal (Mumbai Bench) vide its order dated February 25, 2026 ("the NCLT Order"). The Certified copy of the NCLT Order was filed with Registrar of Companies on March 31, 2026. Consequently, the Scheme become operative
from Closing of business hours on March 31, 2026 and effective from October 1, 2024 i.e. appointed date.
SHARE CAPITALCHANGE IN CAPITAL STRUCTURE
During the year under review, in accordance with the Order dated February 25, 2026 of the Hon'ble National Company Law Tribunal ('NCLT'), in the matter of Scheme of Arrangement between Avalon Cosmetics Private Limited ('the Demerged Company' or 'ACPL') and Vanity Case India Private Limited ('the Transferor Company' or 'VCIPL') and your Company ('the Transferee Company' or the Resulting Company' or 'HFL' or 'the Company') and their respective shareholders ('the Scheme'), your Company's Authorised Share Capital stands increased from existing Rs. 55,15,22,530/- (Rupees Fifty Five Crores Fifteen Lakhs Twenty Two Thousand Five Hundred and Thirty Only) divided into 26,57,61,265 (Twenty Six Crores Fifty Seven Lakhs Sixty One Thousand Two Hundred Sixty Five) Equity Shares of Rs. 2/- (Rupees Two Only) each and 2,00,000 (Two Lakhs) 9% Redeemable Non-Convertible Preference Shares of Rs. 100/- (Rupees One Hundred Only) each to Rs. 55,40,22,530/- (Rupees Fifty Five Crores Forty Lakhs Twenty Two Thousand Five Hundred and Thirty Only) divided into 26,70,11,265 (Twenty Six Crores Seventy Lakhs Eleven Thousand Two Hundred Sixty Five) Equity Shares of Rs. 2/- (Rupees Two Only) each and 2,00,000 (Two Lakhs) 9% Redeemable Non-Convertible Preference Shares of Rs. 100/- (Rupees One Hundred Only) each.
Your Company's Authorised Share Capital as on the date of this report is Rs. 55,40,22,530/- (Rupees Fifty Five Crores Forty Lakhs Twenty Two Thousand Five Hundred and Thirty Only) divided into 26,70,11,265 (Twenty Six Crores Seventy Lakhs Eleven Thousand Two Hundred Sixty Five) Equity Shares of Rs. 2/- (Rupees Two Only) each and 2,00,000 (Two Lakhs) 9% Redeemable Non-Convertible Preference Shares of Rs. 100/- (Rupees One Hundred Only) each.
During the year under review, Two of the Warrants holders of the Preferential issue, named Malabar Select Fund, Qualified Institutional Buyers, Non-Promoter, holding 9,15,331 Warrants having face value of Rs. 2/- (Rupees Two Only) each at a premium of Rs. 544.25/- (Rupees Five Hundred Forty Four and Twenty Five Paisa Only) per share and Bay Capital Holdings Limited, Non-Qualified Institutional Buyers, Non-Promoter, holding 10,64,018
Warrants having face value of Rs. 2/- (Rupees Two Only) each at a premium of Rs. 561.90/- (Rupees Five Hundred Sixty One and Ninety Paisa Only) per shares, had exercised their options aggregating to 19,79,349 (Nineteen Lakhs Seventy Nine Thousand Three Hundred and Forty Nine) for the conversion of Warrants into equivalent number of Equity Shares having face value of Rs. 2/- (Rupees Two Only) each of the Company and upon receipt of an amount aggregating to Rs. 82,49,99,481.71/- (Rupees Eighty Two Crores Forty Nine Lakhs Ninety-Nine Thousand Four Hundred Eighty One and Seventy One Paisa Only), being 75% of the balance amount on the said Warrants, the Share Allotment Committee of your Board of Directors of your Company at their Meeting held on June 18, 2025, had allotted 19,79,349 Equity Shares having face value of Rs. 2/- (Rupees Two Only) each to Malabar Select Fund and Bay Capital Holdings Limited.
Further, the remaining warrant holder, Ms Vanaja Sundar Iyer, Non- Qualified Institutional Buyers, Non-Promoter, had not exercised the option to convert 5,32,009 warrants into Equity Share, hence these warrants lapsed / cancelled and initial amount paid i.e., 25% upfront application money amounting to Rs. 7,49,99,969/- (Rupees Seven Crores Forty Nine Lakhs Ninety Nine Thousand Nine Hundred and Sixty Nine Only) at the time of allotment of warrants, have been forfeited by the Share Allotment Committee of your Board of Directors of your Company at their Meeting held on June 18, 2025, in accordance with the terms of the issue/ allotment and Regulation 169 (3) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018.
As on March 31, 2026, your Company's Issued, Subscribed and Paid-up Share Capital, after Conversion of Convertible Warrants into Equity Shares and Forfeiture/ Cancellation of Warrants as mentioned above, stands increased from existing Rs. 25,10,04,826/- (Rupees Twenty-Five Crores Ten Lakhs Four Thousand Eight Hundred Twenty Six Only) divided into 11,75,02,413 (Eleven Crores Seventy-Five Lakhs Two Thousand Four Hundred Thirteen) Equity Shares of Rs. 2/- (Rupees Two Only) each and 1,60,000 (One Lakhs Sixty Thousand) 9% Redeemable Non-Convertible Preference Shares of Rs. 100/- (Rupees One Hundred Only) each to Rs. 25,49,63,524/- (Rupees Twenty-Five Crores Forty Nine Lakhs Sixty Three Thousands Five Hundred Twenty Four Only) divided into 11,94,81,762 (Eleven Crores
Ninety Four Lakhs Eighty One Thousand Seven Hundred Sixty Two) Equity Shares of Rs. 2/- (Rupees Two Only) each and 1,60,000 (One Lakhs Sixty Thousand) 9% Redeemable Non-Convertible Preference Shares of Rs. 100/- (Rupees One Hundred Only) each.
As at March 31, 2026, no warrants were outstanding for conversion into Equity Shares.
The Nomination and Remuneration Committee of the Board of Directors of your Company at their Meeting held on July 28, 2025, had granted 1,47,100 Stock Options to the eligible Employees of your Company and its Subsidiary Companies. Your Company has not issued any Shares with differential voting rights or by way of Rights issue or Sweat Equity Shares. Further, it has not provided any money to its Employees for purchase of its own Shares hence your Company has nothing to report in respect of Rule 4(4), Rule 12(9) and Rule 16 of the Companies (Share Capital & Debentures) Rules, 2014.
Other / Debt Securities
Your Company has not issued any Debentures during the year under review. No other debt securities had been issued by your Company during the year.
MERGERS AND ACQUISITIONS
During the year under review, your Company obtained the approval and Order dated February 25, 2026, from the Hon'ble NCLT, Mumbai Bench, sanctioning the Scheme of Arrangement under Section 230-232 and other applicable provisions of the Act, the Scheme was between (i) Avalon Cosmetics Private Limited ('the Demerged Company' or 'ACPL'), (ii) Vanity Case India Private Limited ('the Transferor Company' or 'VCIPL') and (iii) Your Company ('the Transferee Company' or the Resulting Company' or 'HFL' or 'the Company'). The Scheme interalia provides for i) De¬ Merger of Nashik business of ACPL with your Company and ii) Merger of VCIPL with your Company. The appointed date was April 01, 2024 for the Demerged Company and October 01, 2024 for the Transferor Company with your Company and the Scheme became effective on closing of business hours on March 31, 2026.
Further, your Company had entered into a Business Transfer Agreement ("BTA") on March 23, 2026 with M/s. Ultra Beauty Care Private Limited and its authorised representatives, for acquisition of manufacturing facility of
Ultra Beauty Care Private Limited situated at C-15, Five Star Industrial Area MIDC Shendra, Aurangabad, Maharashtra, India - 431201 Which is engaged in the business of contract manufacturing of comprehensive range of ayurvedic, herbal beauty care and cosmetic products on a slump sale and going concern basis as per conditions set out in BTA.
During the year under review, your Company had entered into Share Subscription Agreement ("SSA") on August 21, 2025 with Asar Green Kabadi Private Limited ("Asar Green") and its Promoters to acquire 24,643 Series B Compulsorily Convertible Preference Shares ("CCPS") aggregating to 25.07% Share Capital (on a fully diluted basis) of Asar Green, subject to completion of the conditions precedent as set out in the SSA.
During the year under review, HFL Consumer Products Private Limited "HCPPL", a Wholly Owned Subsidiary Company of your Company, entered into a Business Transfer Agreement ("BTA") on November 11, 2025 with M/s. Ashish Industries and M/s. Vijay and its partners and sole traders, for acquisition of manufacturing facility of Ashish Industries situated at Plot No G-21, MIDC, Malegaon, Sinnar, Nashik, and M/s. Vijay situated at Plot No. A -42, MIDC, Malegaon, Sinnar, Nashik ('Business Undertaking'), which are engaged in the business of the Ice-Cream cone manufacturing and sleeves printing and packaging of cones plants ("Undertaking") on a slump sale and going concern basis as per conditions set out in BTA.
This acquisition is in line with your Company's strategy to enter Contract Manufacturing and expansion of its business into bottled water including all its components thereof.
EMPLOYEES STOCK OPTION SCHEME
During the year under review, the Shareholders of your Company approved the Employee Stock Option Scheme 2025 by way of Postal Ballot on April 10, 2025. There has been no material change in the Scheme post its implementation. The Scheme is in compliance of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 ("SEBI SBEB Regulations"). A certificate issued by Pankaj
S. Desai, Practicing Company Secretaries, Mumbai, Secretarial Auditors of your Company confirming that the Scheme has been implemented in accordance with SEBI SBEB Regulations and in accordance with the resolution passed by the Members of your Company, is available
for inspection at the website of your Company at www. hindustanfoodslimited.com.
Further, during the year under review, the Nomination and Remuneration Committee of the Board of Directors of your Company at their Meeting held on July 28, 2025, had granted 1,47,100 Stock Options to the eligible Employees of your Company and its Subsidiary Companies.
The disclosures in compliance of Regulation 14 of the SEBI SBEBSE Regulations, to the extent applicable, are available on your Company's website at www.hindustanfoodslimited.com.
DIVIDEND
To conserve resources and in order to strengthen your Company's financials, your Directors do not recommend any Dividend for the year under review.
DIVIDEND DISTRIBUTION POLICY
In accordance with Regulation 43A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), the top 1000 listed entities based on Market Capitalisation are required to formulate a Dividend Distribution Policy, accordingly your Board has formulated and adopted the Policy. Your Company's Dividend Distribution Policy is based on the parameters laid down by Listing Regulations, and the details of the same are available on your Company's website at www.hindustanfoodslimited.com.
LISTING INFORMATION
Your Company's Equity Shares are listed on BSE Limited ('BSE') and on National Stock Exchange of India Limited ('NSE'). The applicable listing fees for Financial Year 2026-2027 have been paid to the Stock Exchanges before the due dates. The Equity Shares of your Company were not suspended from trading on BSE and NSE at any point of time during the year under review.
DEPOSITORY SYSTEM
Your Company's Equity Shares are available for dematerialisation through National Securities Depository Limited ('NSDL') and Central Depository Services (India) Limited ('CDSL'). As on March 31, 2026, 97.94% of the Equity Shares of your Company were held in Demat form.
ACCREDITATIONS
Your Company continues to enjoy following accreditations:-
1. FSSC 22000 - Food Safety System Certification
2. ISO 9001: 2015 - Quality Management System
3. ISO 14001: 2015 - Environment Management System
4. ISO 45001: 2018 - Occupational Health & Safety Management System
5. ISO 13485: 2016 - Medical Devices - Quality Management Systems
6. I SO 22716: 2007 - Quality Management Systems Cosmetics
7. BRC GS - Global Standard for Consumer products Personal Care and Household
8. BRC GS - GFSI - Global Standard for Food Products
9. Sedex SMETA 4 pillar - Sedex Members Ethical Trade Audit certification
10. USFDA (United States Food and Drug Administration) Registration
11. Russia Federation
12. WHO - Good Manufacturing Practices - Oral Liquid
13. WHO - Good Manufacturing Practices - Tablets & External Preparation
14. Good Manufacturing Practices Certificate - Cosmetic Manufacturing
15. Good Manufacturing Practices Certificate - Ayush PUBLIC DEPOSITS
Your Company has not accepted any deposits from Public / Members falling under the ambit of Section 73 of the Companies Act, 2013 read with the Companies (Acceptance of Deposits) Rules, 2014 during the year under review. Your Company does not have any unpaid/ unclaimed deposits as on March 31, 2026.
SUBSIDIARIES, ASSOCIATES, JOINT VENTURE COMPANIES AND PARTNERSHIP FIRMS / LLP
HFL Consumer Products Private Limited ('HCPPL') continues to be the Wholly Owned Subsidiary of your Company as on date of this report. HCPPL is into the Business for Contract Manufacturing of Ice-Cream, cone manufacturing, sleeves printing and cone packaging.
Your Company continues to hold 81% Partnership interest in Aero Care Personal Products LLP ("ACPPL") as on date of this report and ACPPL is into the Business of manufacturing and trade of Cosmetics, Personal Care and Toiletries Products.
HFL Healthcare and Wellness Private Limited ('HHWPL') continues to be a Wholly-Owned Subsidiary of your Company as on date of this report. HHWPL is into the business of manufacturing and supplying of footcare products and also engaged in the business of OTC Healthcare and Wellness segment as a Contract Manufacturer.
HFL Multiproducts Private Limited ('HMPL'), continues to be a Wholly Owned Subsidiary of your Company as on date of this report. HMPL is into the business of food & beverages for a branded Company and has started business of manufacturing, processing and packaging of bottled water.
KNS Shoetech Private Limited ('KINS'), continues to be a Whoiiy-Owned Subsidiary of your Company as on date of this report. KNS is into the business of manufacturing the entire portfolio of sports shoes and sneakers and open footwear including all their Components thereof. During the year under review KNS was a material subsidiary of your Company as per the Listing Regulations.
During the year under review, your Company had entered into Share Subscription Agreement ("SSA") on August 21, 2025 with Asar Green Kabadi Private Limited ("Asar Green") and its Promoters to acquire 24,643 Series B Compulsorily Convertible Preference Shares ("CCPS") aggregating to 25.07% Share Capital (on a fully diluted basis) of Asar Green. After the said acquisition, Asar Green has become an Associate Company of your Company with effect from August 21, 2025. Asar Green is into the business of waste management, scrap collection, recycling solutions, and circular economy services.
Your Company monitors the performance of all its Subsidiary Companies, inter alia, Financial Statements, in particular investments made by Subsidiary Companies, are reviewed quarterly by your Company's Audit Committee.
Minutes of the Board Meetings of Subsidiary Companies are placed before your Company's Board regularly. A statement containing all significant transactions and arrangements entered into by Subsidiary Companies are
placed before your Board. Presentations are made to your Board on business performance of Subsidiaries of your Company by the Senior Management.
In terms of the Company's Policy on determining "Material Subsidiary" and as defined in Regulation 16(1)(c) of the Listing Regulations, as amended, KNS Shoetech Private Limited identified as Material Subsidiary of your Company with effect from May 19, 2025. Your Company's Policy for determining Material Subsidiary is available on your Company's Website www.hindustanfoodslimited.com.
CONSOLIDATED FINANCIAL STATEMENTS
As stipulated by the Regulation 33 of the Listing Regulations, the Consolidated Financial Statements have been prepared by your Company in accordance with the applicable Accounting Standards. The Audited Consolidated Financial Statements, together with Auditors' Report, forms part of the Annual Report.
Pursuant to Section 129(3) of the Companies Act, 2013, a statement containing the salient features of the Financial Statements of each Subsidiaries, Joint Venture and joint operations in the prescribed Form AOC-1 forms part of the Financial Statements to this Report.
Pursuant to Section 136 of the Companies Act, 2013, the Financial Statements of the Subsidiary and Associate Companies are kept for inspection upon request made by the Shareholders at the Registered Office of your Company. The statements are also available on your Company's website www.hindustanfoodslimited.com.
CREDIT RATING
During the year under review, India Ratings and Research (Ind-Ra) has re-affirmed the Long-Term Issuer Rating to 'IND A / Stable' of your Company. The outlook is Positive.
DIRECTORS' RESPONSIBILTY STATEMENT
To the best of our knowledge and belief and based on the information and representations received from the operating management, your Directors make the following statements in terms of Section 134(3)(c) of the Companies Act, 2013:
(a) that in the preparation of the Annual Accounts, the applicable Accounting Standards have been followed along with the proper explanation relating to material departures;
(b) that such accounting policies as mentioned in Notes to the annual accounts have been selected and applied consistently and judgement and estimates have been made that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company as at March 31, 2026 and of the profit of the Company for the year ended on that date;
(c) that proper and sufficient care has been taken for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 2013 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;
(d) t hat the annual accounts have been prepared on a going concern basis;
(e) that proper internal financial controls are in place and that the internal financial controls are adequate and are operating effectively;
(f) t hat proper systems to ensure compliance with the provisions of all applicable laws are in place and that such systems are adequate and operating effectively.
MANAGEMENT AND KEY MANAGERIAL PERSONNELDIRECTORSRESOLUTIONS TO BE PASSED AT THE ENSUING AGM DIRECTOR LIABLE TO RETIRE BY ROTATION
In accordance with the provisions of Section 152 of the Companies Act, 2013 and the Articles of Association of your Company, Mr Shrinivas Dempo (DIN: 00043413) Non¬ Executive, Non-Independent Director of your Company, retires by rotation at the ensuing Annual General Meeting and being eligible, Mr Shrinivas Dempo offers himself for re-appointment. Your Board has recommended his re-appointment.
The brief resume of Director seeking re-appointment at the ensuing AGM along with other details in pursuance
of Regulation 36(3) of the Listing Regulations is enclosed herewith as Annexure to the Notice of the Annual General Meeting.
KEY MANAGERIAL PERSONNEL
Pursuant to the provisions of Section 2(51) and Section 203 of the Companies Act, 2013, Mr Sameer R Kothari, Managing Director, Mr Ganesh Argekar, Whole-time Director, Mr Mayank Samdani, Chief Financial Officer and Mr Bankim Purohit, Company Secretary and Legal Head are the Key Managerial Personnel of your Company.
INDEPENDENT DIRECTORS' DECLARATION
Pursuant to Section 149(7) of the Companies Act, 2013, your Company has received declarations from all the Independent Directors of your Company viz. Mr Shashi K Kalathil, Ms Honey Vazirani, and Mr Neeraj Chandra confirming that they meet the criteria of independence as prescribed under Section 149 (6) of the Companies Act, 2013 and Regulation 16(b) of the Listing Regulation in respect of their position as an "Independent Director" of your Company. In terms of provisions of Section 134(3) (d) of the Companies Act, 2013, the Board of Directors of your Company have taken note of all these declarations of independence received from all the Independent Directors and have undertaken due assessment of the veracity of the same.
Further, the Independent Directors of your Company have confirmed that, they are not aware of any circumstance or situation, which could impair or impact their ability to discharge duties with an objective independent judgment and without any external influence.
Your Board is of the opinion that, the Independent Directors of your Company possess requisite qualifications, experience, expertise (including proficiency) and they hold the highest standards of integrity that enables them to discharge their duties as the Independent Directors of your Company. Further, in compliance with Rule 6(1) of the Companies (Appointment and Qualification of Directors) Rules, 2014, all Independent Directors of your Company have registered themselves with the Indian Institute of Corporate Affairs.
FAMILIARISATION PROGRAMMES
Familiarisation programmes for the Independent Directors were conducted during the Financial Year 2025-2026. Apart from this, there were quarterly business presentations by Mr Ganesh T Argekar, Executive Director (ED) of your Company. Details of the familiarisation programme are explained in the Corporate Governance Report and are also available on your Company's website and can be accessed at www.hindustanfoodslimited.com.
MEETINGS OF THE BOARD OF DIRECTORS
A minimum of 4 (Four) Board Meetings are held annually. Additional Board Meetings are convened by giving appropriate Notice to address the Company's specific needs and business Agenda. The Meetings of your Board of Directors are pre-scheduled and intimated to all the Directors in advance in order to help them plan their schedule. In case of business exigencies or urgency of matters, approvals are taken by convening the Meetings at a Shorter Notice with consent of the Directors or by passing resolutions through circulation as permitted under the applicable law, which are noted and confirmed in the subsequent Board and Committee Meetings.
During the year under review, the Board of Directors of your Company met 5 (Five) times viz. on May 19, 2025, August 8, 2025, October 15, 2025, November 12, 2025 and February 10, 2026. The details of the Board Meetings and the attendance records of the Directors are provided in the Corporate Governance Report which forms part of this Annual Report.
SEPARATE MEETING OF INDEPENDENT DIRECTORS
Pursuant to Schedule IV of the Companies Act, 2013 and Regulation 25(3) of the Listing Regulations, the Independent Directors of your Company are required to hold at least one Meeting in a Financial Year without attendance of Non-Independent Directors and Members of the Management.
During the Financial Year 2025-2026, the Independent Directors of your Company met twice on May 19, 2025 and November 12, 2025. All the Independent Directors were present at the Meeting.
ANNUAL EVALUATION OF BOARD'S PERFORMANCE
Pursuant to the provisions of the Companies Act, 2013 and Regulation 17(10) of the Listing Regulations your Board has carried out the annual performance evaluation of its own performance, the Directors individually as well as the evaluation of the working of the Board and its Statutory Committees. Further, the performance evaluation criteria for Independent Directors included a check on their fulfilment of the independence criteria and their independence from the Management.
Based on various criteria, the performance of the Board, various Board Committees, Chairman and Individual Directors (including Independent Directors) was found to be satisfactory.
AUDIT COMMITTEE
The Audit Committee comprises of 3 (Three) Members, out of which 2 (Two) are Independent Directors. Mr Shashi K Kalathil, Independent Director, serves as the Chairman of the Committee. Ms Honey Vazirani and Mr Ganesh Argekar are the other Members of the Committee.
The terms of reference, number of Meetings held during the Financial Year and other information of the Audit Committee are provided in Corporate Governance Report which forms part of this Annual Report.
All the recommendations made by the Audit Committee during the Financial Year under review were accepted by the Board.
NOMINATION AND REMUNERATION COMMITTEE
The Nomination and Remuneration Committee comprises of 3 (Three) Members out of which 2 (Two) are Independent Directors. Ms Honey Vazirani, Independent Director, who serves as the Chairperson of the Committee, Mr Shashi K Kalathil and Mr Shrinivas Dempo are the other Members of the Committee.
The terms of reference, number of Meetings held during the Financial Year under review and other informations of the Nomination and Remuneration Committee are provided in Corporate Governance Report which forms part of this Annual Report.
The Committee has formulated a Nomination and Remuneration Policy and the same has been uploaded on the website of your Company at www. hindustanfoodslimited.com.
STAKEHOLDERS RELATIONSHIP COMMITTEE
The Committee comprises of 4 (Four) Members out of which 2 (Two) are Independent Directors. Mr Neeraj Chandra, Independent Director, serves as the Chairman of the Committee, Mr Shrinivas Dempo, Ms Honey Vazirani and Mr Sameer Kothari are the other Members of the Committee.
The composition, terms of reference, number of Meetings held during the Financial Year under review and other informations of the Stakeholders Relationship Committee are provided in Corporate Governance Report which forms part of this Annual Report.
CORPORATE SOCIAL RESPONSIBILITY (CSR) COMMITTEE
As required under the Companies Act, 2013, a CSR committee of the Board is duly constituted to formulate and recommend to the Board, the CSR Policy indicating the Company's CSR activities to be undertaken. The CSR Policy as recommended by the Committee and as approved by your Board is available on your Company's website viz. www.hindustanfoodslimited.com.
The CSR Committee comprises of 3 (Three) Members out of which 1 (One) is Independent Director. Mr Sameer Kothari, Managing Director, serves as the Chairman of the Committee. Mr Ganesh Argekar and Mr Shashi K Kalathil are the other Members of the Committee.
The terms of reference, number of Meetings held during the year and details of the role and functioning of the committee are given in the Corporate Governance Report which forms part of this Annual Report.
During the year under review, your Company took various initiatives towards supporting projects in the area of Education, Welfare, Healthcare and Safety Measures, Rehabilitation of homeless young women and providing various facilities to senior citizens and needy peoples. Based on the recommendation of the CSR Committee for the amount of expenditure to be incurred on the CSR activities, your Board and the Management of your Company had
contributed towards the specified activities laid down under your Company's policy on expenditure on CSR.
The Annual Report on CSR activities as required under the Companies (Corporate Social Responsibility Policy) Rules 2014 is set out as Annexure I forming part of this Annual Report.
RISK MANAGEMENT COMMITTEE
Knowing the importance of managing and pre-empting risks effectively for sustaining profitable business, your Company has constituted a Risk Management Committee, in line with the Listing Regulations, as it is covered and applicable to the top 1000 Listed entities.
The Risk Management Committee comprises of 6 (Six) Members out of which 2 (Two) are Independent Directors. Mr Sameer Kothari, Managing Director, serves as the Chairman of the Committee. Mr Ganesh Argekar, Mr Shashi K Kalathil, Ms Honey Vazirani, Mr Mayank Samdani and Mr Bankim Purohit are the other Members of the Risk Management Committee of your Board.
The terms of reference, number of Meetings held during the Financial Year and details of the role and functioning of the committee are given in the Corporate Governance Report which forms part of this Annual Report.
SHARE ALLOTMENT COMMITTEE
The Share Allotment Committee comprises of 4 (Four) Members out of which 1 (One) is Independent Director. Mr Shashi K Kalathil, Independent Director, serves as the Chairman of the Committee. Mr Sameer Kothari, Mr Ganesh Argekar and Mr Mayank Samdani are the other Members of the Committee.
The terms of reference, number of Meetings held during the Financial Year under review and other informations of the Share Allotment Committee are provided in Corporate Governance Report which forms part of this Annual Report.
DETAILS OF UTILISATION OF FUNDS RAISED THROUGH PREFERENTIAL ALLOTMENT
Your Company had raised Rs. 175 cr against receipt of being 25% upfront money against preferential issue of warrant and received 75% of the balance amount against
the part conversion of warrants into Equity Shares in the Financial Year 2023-2024. From time to time, your Company has converted warrants into Equity Shares on receipt of balance 75% from the warrant holders. As on March 31, 2026, your Company has raised aggregating to Rs. 377.50 cr through preferential issue.
Further, During the Financial Year 2025-2026, your Company had obtained a Shareholders approval for the variation, deviation of the unutilised proceeds raised through preferential issue in its Meeting held on September 23, 2025.
The details of the funds raised, objects and amount of deviation, if any is provided in the below table:
|
Sr.
No
|
Original Object
|
Amount proposed in the offer document/ revised by the Shareholders
|
Particulars of Issue
|
Utilisation of funds raised
|
|
1
|
Funding Inorganic growth opportunities and strategic acquisition
|
108.125
|
The Company had received Rs. 99,99,99,470.24/- i.e. 25% of the issue price for allotment of 72,71,081 Convertible Warrants on December 20, 2023.
The Company had allotted 18,30,663 Equity Shares on February 2, 2024 on receipt of Rs. 74,99,99,748/- (Rupees Seventy-Four Crores Ninety-Nine Lakhs Ninety-Nine Thousand Seven Hundred Forty Eight Only).
The Company had further allotted 29,29,060 Equity Shares on December 28, 2024 on receipt of Rs. 1,19,99,99,267/- (Rupees One Hundred Nineteen Crores Ninety-Nine Lakhs Ninety-Nine Thousand Two Hundred Sixty Seven Only).
The Company has further allotted 19,79,349 Equity Shares on June 18, 2025 on receipt of Rs. 82,49,99,481.71/- (Rupees Eighty Two Crores Forty Nine Lakhs Ninety-Nine Thousand Four Hundred Eighty One and Seventy One Paisa Only).
|
103.09
|
|
2
|
Funding capital expenditure for new green field projects
|
|
|
|
a.
|
Greenfield project of the Company
|
60.000
|
53.08
|
|
b.
|
Greenfield project of the Subsidiary Company
|
45.000
|
24.06
|
|
3
|
Funding capital expenditure for Brown field projects
|
|
|
|
a.
|
Brown field project of the Company
|
45.000
|
42.28
|
|
b.
|
Brown field project of the Subsidiary Company
|
25.000
|
24.82
|
|
4
|
General Corporate purpose
|
90.875
|
74.25
|
|
5
|
Issue Expenses
|
3.500
|
-
|
-
|
| |
TOTAL
|
377.50
|
|
321.58
|
There is no deviation or variation in the utilisation of funds from the objects stated in the Explanatory Statement to the Notice for the Extra Ordinary-General Meeting held for approval of Preferential allotment of Warrants. The funds raised through the respective issues were utilised for the purpose for which it was raised and in accordance with the objects of the said Preferential issue.
Pursuant to the provisions of Regulation 32 of the Listing Regulation the necessary disclosures were submitted with the Stock Exchanges and is available on website of your Company viz. www.hindustanfoodsUmited.com.
INTERNAL CONTROL SYSTEM
Your Board has laid down Internal Financial Controls ('IFC') within the meaning of the explanation to Section 134 (5) (e) of the Companies Act, 2013. Your Board believes that, your Company has sound IFC commensurate with the nature and size of its business. Business is however dynamic. Your Board is seized of the fact that IFC are not static and are in fact a fluid set of tools which evolve over time as the business, technology and fraud environment changes in response to competition, industry practices, legislation, regulation and current economic conditions. There will therefore be gaps in the IFC as business evolves. Your Company has a process in place continuously identify such gaps and implement newer and or improved controls wherever the effect of such gaps would have a material effect on the Company's operations.
PARTICULARS OF EMPLOYEES AND RELATED DISCLOSURES
The information required under Section 197(12) of the Companies Act, 2013 read with the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 and forming part of the Directors' Report for the year ended March 31, 2026 is given in a separate Annexure to this Report as Annexure II.
The Annexure in pursuance to the Rule 5 (2) of the Companies (Appointment and Remuneration) Rules, 2014, is not being sent along with this Report to the Members of your Company in line with the provisions of Section 136 of the Companies Act, 2013. Members who are interested in obtaining these particulars may write to the Company Secretary and Legal Head at the Registered Office of the Company. The aforesaid Annexure is also available for inspection by the Members at the Registered Office of the Company, 21 days before the 41st Annual General Meeting and up to the date of the ensuing Annual General Meeting during the business hours on working days.
AUDITORS1. Statutory Auditors
Pursuant to the requirements of Section 139(2) of the Companies Act, 2013 ('the Act'), M/s M S K A & Associates LLP, Chartered Accountants (Registration No.105047W) were appointed as a Statutory Auditors of your Company for a Second term of 5 (Five) consecutive years from the 37th Annual General Meeting held on September 22, 2022 till the conclusion of the 42nd Annual General Meeting to be held in the FY 2026-2027. As per notification issued by the Ministry of Corporate Affairs dated May 07, 2018, ratification of the Statutory Auditors at the Annual General Meeting is not required.
2. Cost Auditors
Pursuant to Section 148 of the Act read with the Companies (Cost Records and Audit) Rules, 2014, your Company is required to prepare, maintain as well as have the audit of its cost records conducted by a Cost Accountant and accordingly it has maintained such cost records. Your Board on recommendation of the Audit Committee of the Board of Directors in their Meeting held on August 4, 2026 has appointed
M/s Poddar & Co., Cost Accountants (Firm Registration No: 101734) as the Cost Auditors of your Company for the FY 2026-2027 under Section 148 and all other applicable provisions of the Act.
M/s Poddar & Co. have confirmed that they are free from disqualification specified under Section 141 (3) and proviso to Section 148 (3) read with Section 141(4) of the Companies Act, 2013 and that the appointment meets the requirements of Section 141 (3) (g) of the Companies Act, 2013. They have further confirmed their independent status.
The remuneration payable to the Cost Auditor is required to be placed before the Members in the General Meeting for their ratification. Accordingly, a Resolution for seeking Members' ratification for the remuneration payable to M/s Poddar & Co. is included at Item No. 3 of the Notice convening the ensuing AGM.
M/s Poddar & Co., Cost Accountants have carried out the Cost Audit for applicable businesses during the year. There are no qualifications, reservations or adverse remarks or disclaimer made in the Cost Auditors' Report for the Financial Year 2025-2026, which requires any clarification or explanation.
3. Secretarial Auditors
Pursuant to the provisions of Section 204 of the Act and Regulation 24A of Listing Regulations, CS Pankaj S Desai, Practicing Company Secretary (COP no. 4098 & Membership no. 3398), were appointed as Secretarial Auditors of the Company, for a term of five consecutive years i.e. from FY 2025-2026 to FY 2029-2030.
CS Pankaj S Desai, Practicing Company Secretary has confirmed, he is not disqualified from being appointed as the Secretarial Auditors of the Company under the amended SEBI regulations and satisfy the prescribed eligibility criteria.
The Secretarial Audit Report for the Financial Year ended March 31, 2026 forms a part of this Annual Report as Annexure III. The Secretarial Audit Report and Secretarial Compliance Report for the Financial year 2025-2026, does not contain any qualification, reservation, or adverse remark.
As per the requirements of the Listing Regulations, CS Pankaj S Desai, Practicing Company Secretary, have undertaken Secretarial Audit of KNS Shoetech Private Limited, Material Subsidiary of your Company for the FY 2025-2026. The Secretarial Audit Report for the Financial Year ended March 31, 2026 is annexed as Annexure - IIIA to this Report.
STATUTORY AUDITORS' OBSERVATIONS
The notes on Financial Statements referred to in the Statutory Auditor's Report are self-explanatory and therefore, do not call for any further explanations or comments.
There are no qualifications, reservations or adverse remarks or disclaimer made in the Statutory Auditors' Report which requires any clarification or explanation.
ANNUAL SECRETARIAL COMPLIANCE REPORT
Pursuant to Regulation 24 (A) of the Listing Regulations, the Independent Secretarial Auditor, CS Pankaj S Desai, Practicing Company Secretary (COP no 4098 & Membership no. 3398) had undertaken an audit for the Financial Year 2025-2026 for the SEBI compliances, it does not contain any qualification, reservation, or adverse remark. The Annual Secretarial Compliance Report has been submitted to the Stock Exchanges within 60 days of the end of the Financial Year.
VIGIL MECHANISM / WHISTLE BLOWER POLICY
Your Company has established a Mechanism for the Directors and Employees to report their genuine concerns or grievances about unethical behavior, actual or suspected fraud or violation of the Code. It also provides for adequate safeguards against victimisation of Employees who avail the mechanism and allows direct access to the Chairperson of the Audit Committee in exceptional cases. The Whistle Blower Policy also facilitates all Employees of your Company to report any instances of leak of Unpublished Price Sensitive information. This policy is also posted on the website of your Company at www.hindustanfoodslimited. com. The Audit Committee of your Company oversees the Vigil Mechanism.
RISK MANAGEMENT
Your Company follows well-established and detailed risk assessment and minimisation procedures, which are periodically reviewed by the Risk Management Committee and Board. Your Company has in place a business risk management framework for identifying risks and opportunities that may have a bearing on the organisation's objectives, assessing them in terms of likelihood and magnitude of impact and determining a response strategy.
The Senior Management assists your Board in its oversight of the Company's management of key risks, including strategic and operational risks, as well as the guidelines, policies and processes for monitoring and mitigating such risks under the aegis of the overall business risk management framework.
The Risk Management policy is uploaded on the website of your Company and can be accessed at www. hindustanfoodslimited.com.
BUSINESS RESPONSIBILITY AND SUSTAINABILITY REPORTING ('BRSR')
As stipulated under the Regulation 34(2)(f) of the Listing Regulations and SEBI circular no. SEBI/LAD-NRO/ GN/2021/22 dated May 05, 2021 read with SEBI circular no. SEBI/HO/ CFD/CFD-SEC-2/P/CIR/2023/122 dated July 12, 2023 and recent circular dated March 28, 2025, circular no. SEBI/HO/ CFD/CFD-PoD-1/P/CIR/2025/42 your Company provides the prescribed disclosures in new reporting requirements on Environmental, Social and Governance ('ESG') parameters called the Business Responsibility and Sustainability Report ('BRSR') which includes performance against the nine principles of the National Guidelines on Responsible Business Conduct and the report under each principle which is divided into essential and leadership indicators, forms part of this Annual Report.
PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS
The details of Loans, Guarantees and Investments covered under the provisions of Section 186 of the Act read with the Companies (Meetings of Board and its Powers) Rules, 2014 are given in the Notes to the Financial Statements.
RELATED PARTY TRANSACTIONS
As required under Regulation 23(1) of the Listing Regulations, your Company has formulated a policy on dealing with Related Party Transactions. The Policy has been uploaded on your Company's website: www. hindustanfoodslimited.com.
The transactions entered with Related Parties for the year under review were on arm's length basis and in the ordinary course of business. All the transactions with Related Parties are placed before the Audit Committee and also the Board for their approval. Prior Omnibus approval of the Audit Committee and approval of your Board is obtained for the transactions which are foreseeable and a repetitive of nature. The transactions entered into pursuant to the approvals so granted are subjected to audit and a statement giving details of all Related Party Transactions is placed before the Audit Committee and the Board of Directors on a quarterly basis. Further, there were no material Related Party Transactions during the year under review with the Promoters, Directors or Key Managerial Personnel which may have a potential conflict with the interest of the Company. Accordingly, no transactions are required to be reported in Form No. AOC-2 in terms of Section 134 of the Act read with Rule 8 of the Companies (Accounts) Rules, 2014.
SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS
There are no significant material orders passed by the Regulators or Courts or Tribunals which would impact the going concern status of your Company and its future operations.
MATERIAL CHANGES BETWEEN THE DATE OF THE BOARD REPORT AND END OF FINANCIAL YEAR
There are no material changes and commitments, affecting the financial position of your Company, which has occurred between the end of the Financial Year of your Company i.e. March 31, 2026 and the date of Board's Report i.e. August 4, 2026 except;
Pursuant to the Scheme of Arrangement, your Company, at the Meeting of the Share Allotment Committee of the Board of Directors held on May 21, 2026, allotted 4,81,39,085 (Four Crores Eighty-One Lakhs Thirty-Nine Thousand and Eighty-Five) fully paid-up Equity Shares of
face value of Rs. 2/- (Rupees Two Only) each, issued at par. This allotment included shares issued against fractional entitlements, and was made to the eligible Shareholders of the Demerged Company and the Transferor Company in accordance with the provisions of the Scheme.
The fractional entitlements arising under the Scheme in respect of the Shareholders of the Demerged Company and the Transferor Company were consolidated. The corresponding Equity Shares were allotted to the Hindustan Foods Limited - Fractional Shares Trust, for which Axis Trustee Services Limited acts as the Trustee.
Subsequently, pursuant to allotment of 4,64,58,145 Equity Shares to the eligible Shareholders of Transferor Company and in accordance with Clause 19 and 21 of the Scheme, 4,64,58,145 Equity Shares held by Transferor Company in the Company were cancelled upon the Scheme becoming effective and equivalent number of shares were allotted to the shareholders of the Transferor Company in the proportion of their shareholding in the Transferor Company.
The Issued, Subscribed and Paid-up Share Capital as on the date of this report after the said allotment, stands increased from existing Rs. 25,49,63,524/- (Rupees Twenty-Five Crores Forty Nine Lakhs Sixty Three Thousands Five Hundred Twenty Four Only) divided into 11,94,81,762 (Eleven Crores Ninety Four Lakhs Eighty One Thousand Seven Hundred Sixty Two) Equity Shares of Rs. 2/- (Rupees Two Only) each and 1,60,000 (One Lakhs Sixty Thousand) 9% Redeemable Non-Convertible Preference Shares of Rs. 100/- (Rupees One Hundred Only) each to Rs. 25,83,25,404/- (Rupees Twenty-Five Crores Eighty Three Lakhs Twenty Five Thousands Four Hundred Four Only) divided into 12,11,62,702 (Twelve Crores Eleven Lakhs Sixty Two Thousand Seven Hundred Two) Equity Shares of Rs. 2/- (Rupees Two Only) each and 1,60,000 (One Lakhs Sixty Thousand) 9% Redeemable Non-Convertible Preference Shares of Rs. 100/- (Rupees One Hundred Only) each.
REPORTING OF FRAUDS BY AUDITORS
During the year under review, neither the Statutory Auditors nor the Secretarial Auditors nor the Cost Auditors reported to the Audit Committee of the Board, any instances of fraud committed against your Company by its officers or Employees, the details of which would need to be mentioned in this Report under section 143(12) of the Companies Act, 2013.
• No shares with differential voting rights and sweat equity shares have been issued;
• Managing Director & CEO has not received any remuneration or commission from any of its subsidiaries;
• There is no application made or pending proceeding under the Insolvency and Bankruptcy Code, 2016 (31 of 2016);
• There was no instance of one time settlement with any Bank or Financial Institution.
MANAGEMENT DISCUSSION & ANALYSIS REPORT
Pursuant to Regulation 34 of the Listing Regulations, the Management Discussion and Analysis Report is presented in a separate section forming part of this Annual Report highlighting the detailed review of operations, performance and future outlook of your Company.
ENERGY CONSERVATION, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO
The information in respect of matters pertaining to conservation of energy, technology absorption, Foreign exchange earnings and outgo, as required under Section 134 (3)(m) of the Companies Act, 2013 read with Rule 8(3) of the Companies (Accounts) Rules, 2014 are provided in the Annexure - IV to this Report.
ANNUAL RETURN
Pursuant to the provisions of Section 134 (3) (a) and Section 92 (3) of the Act read with Rule 12 of the Companies (Management and Administration) Rules, 2014, the Annual Return of your Company for the Financial Year March 31, 2026 is uploaded on the website of your Company and can be accessed at www.hindustanfoodsUmited.com.
DISCLOSURES UNDER SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013
In accordance with the provisions of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 and the rules made there under, your Company has formulated an Internal Policy on Sexual Harassment at Workplace (Prevention, Prohibition and Redressal) and circulated to all the Employees, which provides for a proper mechanism for redressal of complaints of sexual harassment.
Your Company is committed to creating and maintaining an atmosphere in which Employees can work together without fear of sexual harassment, exploitation or intimidation. Your Board has constituted Internal Complaints Committees (ICCs) pursuant to the provisions of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 and the Rules framed thereunder. ICCs is responsible for redressal of complaints related to sexual harassment at the workplace in accordance with procedures, regulations and guidelines provided in the Policy.
During the year under review, there were no complaints received under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013. Accordingly, the Internal Complaints Committee (ICC) report is presented below with 'Nil' entries:
|
Number of complaints of sexual harassment received in the year;
|
NIL
|
|
Number of complaints disposed off during the year
|
NIL
|
|
Number of cases pending more than ninety days
|
NIL
|
Your Company is in compliances with the provisions relating to Maternity Benefit Act 1961.
COMPLIANCE WITH SECRETARIAL STANDARDS
Your Company is in compliance with the applicable Secretarial Standards issued by the Institute of Company Secretaries of India (ICSI) and approved by the Central Government under Section 118 (10) of the Companies Act, 2013.
CORPORATE GOVERNANCE
It has been the endeavor of your Company to follow and implement best practices in Corporate Governance, in letter and spirit. The following forms part of this Annual Report:
(i) Declaration regarding compliance of Code of Conduct by Board Members and Senior Management Personnel;
(ii) Management Discussion and Analysis Report;
(iii) Report on Corporate Governance and;
(iv) Practicing Company Secretary Certificate regarding compliance of conditions of Corporate Governance.
(v) Practicing Company Secretary Certificate confirming that none of the Director of your Company are disqualified as the Director of your Company.
OTHER DISCLOSURES
No disclosure or reporting is made with respect to the following items, as there were no transactions during the year under review:
• There was no change in the nature of business;
APPRECIATION AND ACKNOWLEDGEMENT
Your Directors would like to express their appreciation for the assistance and co-operation received from the Government authorities, banks, customers, business associates and Members during the year under review. Your Directors also wish to place on record their deep sense of appreciation for the committed services by the executives, staff and workers of the Company during the year under review.
For and on behalf of the Board of Directors
Sameer R Kothari Ganesh T Argekar
Place: Mumbai Managing Director Executive Director
Date : August 4, 2026 DIN: 01361343 DIN: 06865379
|